Could a camera replace the mask in head and neck cancer radiotherapy?
NCT ID NCT06627075
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial explores whether a surface camera system can guide radiotherapy for head and neck cancer without the usual tight restraint mask. Instead, patients lie in a moulded vacuum mattress, and the camera tracks their position continuously during each session, automatically stopping the beam if they move too much. The study will measure how much patients move during treatment to see if this mask-free approach is precise enough. If it works, it could make radiotherapy sessions more comfortable for people with head and neck cancer.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Surface-guided radiotherapy (SGRT) without a restraint mask
- What this could lead to
- If successful, this could make radiotherapy for head and neck cancer more comfortable by removing the need for a tight mask, while maintaining precise targeting.
- What could go wrong
- This is a small feasibility study, so results may not apply broadly. There is a risk that patient movement without the mask could reduce treatment accuracy, and the approach may not be suitable for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
42 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients over 18 years of age * Patients undergoing palliative or curative treatment for oro-rhino-laryngeal cancer * Patients with an indication for radiotherapy treatment, with or without complementary treatment (chemotherapy, immunotherapy), with a number of sessions between 10 and 35 * Patients who have dated and signed an informed consent form Exclusion Criteria: * Patients with uncontrollable movements * Patients under psychiatric care * Patients who do not understand or read French * Patients participating in an interventional study testing another medical intervention * Patients under guardianship, curatorship, safeguard of justice or deprived of liberty * Pregnant or breast-feeding women * Patients without social security coverage
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Otorhinolaryngeal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre de Lutte contre le Cancer Eugène Marquis
Rennes, Brittany Region, 35042, France